指南与共识乳腺技术与安全PETCT

18F-氟脱氧葡萄糖正电子发射断层扫描联合计算机断层扫描在早期乳腺癌管理中的应用:香港乳腺癌基金会PET/CT研究组基于共识的本地建议

Use of 18F-fluorodeoxyglucose positron emission tomography coupled with computed tomography in early breast cancer management: consensus-based local recommendations by the Hong Kong Breast Cancer Foundation PET/CT Study Group.
指南 / 共识 · Hong Kong Med J · 2025-11-12

该共识由香港乳腺癌基金会PET/CT研究组制定,通过文献检索(2023年9月,PubMed关键词「breast cancer」和「PET/CT」)及国际主要癌症机构指南回顾,起草10条推荐声明,经两轮改良德尔菲共识流程(2023年12月19日至2024年2月29日),76名专家参与第一轮,71名完成第二轮(应答率93.4%),最终就8条声明达成共识。

要点

  • 共识涉及早期乳腺癌管理中PET/CT的应用,共10条推荐声明。
  • 第一轮达成7条共识,第二轮新增1条,合计8条达成共识。
  • 专家组包括肿瘤科、外科及放射科(含核医学放射科)医生。

核心结论

  • 通过共识流程提出的建议有望作为本地医疗专业人员使用PET/CT管理早期乳腺癌的指导,获得更广泛的接受和认可。

研究设计与样本

  • 共识制定:文献检索于2023年9月在PubMed进行,关键词为「breast cancer」和「PET/CT」,并回顾主要国际癌症机构指南,起草10条推荐声明,采用两轮改良德尔菲共识流程,为期3个月(2023年12月19日至2024年2月29日)。

诊断标准与关键数值

  • 第一轮76名专家同意参与,第二轮71名完成并纳入专家组,第二轮应答率93.4%。
  • 专家组构成:肿瘤科医生30名(42.3%),外科医生35名(49.3%),放射科医生(包括核医学放射科医生)6名(8.5%)。
  • 专家来源:医院管理局37名(52.1%),私营部门32名(45.1%),两所本地大学医学院之一2名(2.8%)。
  • 超过75%的专家组成员具有至少15年临床经验。
  • 10条声明中,第一轮达成7条共识,第二轮新增1条达成共识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: 18F-fluorodeoxyglucose positron emission tomography coupled with computed tomography (PET/CT) has been incorporated into breast cancer management. In Hong Kong, PET/CT use is increasing. This study aimed to establish consensus-based recommendations on the use of PET/CT in the management of early breast cancer.

METHODS: A literature search was conducted in September 2023 using the keywords "breast cancer" and "PET/CT" within PubMed to identify research articles related to the use of PET/CT in early breast cancer. Guidelines from major international cancer agencies were also reviewed. Ten recommendation statements were drafted. A two-round modified Delphi consensus process was conducted over a 3-month period (19 December 2023 to 29 February 2024).

RESULTS: A total of 76 experts consented to participate in the first round, of whom 71 completed the second round and were included as members of the expert panel, yielding a second-round response rate of 93.4%. The panel comprised oncologists (n=30, 42.3%), surgeons (n=35, 49.3%), and radiologists (including nuclear medicine radiologists) [n=6, 8.5%]. Experts from the Hospital Authority (n=37, 52.1%) and the private sector (n=32, 45.1%) were well represented. Two experts (2.8%) were from one of the two local university medical faculties. Over 75% of expert panel members had at least 15 years of clinical experience. Of the ten statements, consensus was achieved on seven in the first round and one additional statement in the second round.

CONCLUSION: Through the consensus process, the proposed recommendations are expected to gain wider acceptance and recognition among local healthcare professionals as guidance for the use of PET/CT in early breast cancer management.

来源:Hong Kong Med J,查看原文。版权归原作者所有。

引用

  1. Kwok CCH, Wong HCY, Wong CYH, et al. Use of 18F-fluorodeoxyglucose positron emission tomography coupled with computed tomography in early breast cancer management: consensus-based local recommendations by the Hong Kong Breast Cancer Foundation PET/CT Study Group. Hong Kong Med J. 2025. PMID: 41220140. doi:10.12809/hkmj2411789

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。